Corcept Therapeutics Incorporated
CORT
$115.70
$1.721.51%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 42.99M | -31.76M | 24.29M | 19.67M | 35.15M |
| Total Depreciation and Amortization | 863.00K | 598.00K | 482.00K | 477.00K | 469.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 31.59M | 9.10M | 4.49M | 30.99M | -53.00K |
| Change in Net Operating Assets | -41.90M | 5.29M | 9.19M | 3.35M | 8.73M |
| Cash from Operations | 33.54M | -16.77M | 38.45M | 54.48M | 44.30M |
| Capital Expenditure | -2.53M | -201.00K | -50.00K | 0.00 | -57.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -26.71M | 4.74M | -11.79M | 14.65M | 70.18M |
| Cash from Investing | -29.24M | 4.54M | -11.84M | 14.65M | 70.13M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 9.42M | 6.52M | 5.32M | 4.20M | 12.51M |
| Repurchase of Common Stock | -11.46M | -5.76M | -36.54M | -50.62M | -115.44M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -2.04M | 760.00K | -31.22M | -46.41M | -102.93M |
| Foreign Exchange rate Adjustments | 37.00K | -287.00K | -32.00K | -320.00K | 1.44M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.30M | -11.76M | -4.64M | 22.39M | 12.93M |